Evidence map›Paper›PMID 36849750›Full record

ArticleSurgical case reports2023

A long-term survival case of histiocytic sarcoma by surgery alone in a Japanese elderly breast tumor patient.

Toru Higuchi, Chih-Ping Li, Yuko Hirota, Yuji Hayashi, Fumio Arisawa, Ikuko Manabe, Takashi Sakurai, Akiko Adachi, Tsuyoshi Saito

Open access · goldAbstract read
In one paragraph

Article in Surgical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Toru HiguchiBreast Unit, Japanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuoh-Ku, Saitama, 330-8553, Japan. higuchitohru@gmail.com.ORCID http://orcid.org/0000-0001-6325-6124
Chih-Ping LiDepartment of Pathology, Japanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuoh-Ku, Saitama, 330-8553, Japan.
Yuko HirotaDepartment of Pathology, Japanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuoh-Ku, Saitama, 330-8553, Japan.
Yuji HayashiBreast Unit, Japanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuoh-Ku, Saitama, 330-8553, Japan.
Fumio ArisawaBreast Unit, Japanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuoh-Ku, Saitama, 330-8553, Japan.
Ikuko ManabeDepartment of Nursing, Japanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuoh-Ku, Saitama, 330-8553, Japan.
Takashi SakuraiBreast Unit, Japanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuoh-Ku, Saitama, 330-8553, Japan.
Akiko AdachiDepartment of Pathology, Japanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuoh-Ku, Saitama, 330-8553, Japan.
Tsuyoshi SaitoBreast Unit, Japanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuoh-Ku, Saitama, 330-8553, Japan.
Saitama Red Cross Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHistiocytic sarcoma (HS) is a rare hematologic malignancy. HS of the breast is extremely rare, and we present a case of an elderly patient with breast HS. CASE PRESENTATION: An 81-year-old woman with unremarkable past medical and family histories presented to our hospital with a palpable mass in her right upper breast. She had noticed a mass in her right breast 3 months before her first visit. Physical examination revealed a mass measuring approximately 30 mm in the right upper quadrant of the breast; there were no cervical or axillary lymphadenopathies. Mammography revealed a high-concentration mass with unclear margins in the upper and outer breast. Ultrasound and magnetic resonance imaging (MRI) revealed a 31 × 23-mm nodule with a relatively clear margin and necrotic sign on the T2-intensified image. A mastectomy was performed upon the patient's request, and the surgical specimen revealed a 35-mm hemorrhagic mass. The lesion was estrogen receptor-, progesterone receptor-, and HER2/neu-negative. The Ki-67 labeling index was approximately 30%. The immunohistochemical panel showed immune reactivity for the histiocytic markers CD68, CD163, and CD206 and was immune-negative for B lineage, T lineage, Langerhans cells, and keratins. The diagnosis of HS was based on the morphological and immunophenotypic characteristics of the mass. The patient received no systemic therapy and survived for 50 months without recurrence.

conclusionsHere, we report the case of an elderly patient with rare breast HS. Although the prognosis of HS seems poor, the breast HS was not as poor as expected, since it might have been discovered in the local region before it metastasized.

Indexed as

Breast tumorCase reportGeriatric oncologyHistiocytic sarcomaMammographyMastectomyPrognosis

Identifiers

PMID36849750
PMCPMC9971399
OpenAlexW4322617671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.